Zimmer Biomet Announces Second Quarter 2024 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/23/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
- One killed, three injured when man attacks Swedish school with sword
Zimmer Biomet (ZBH) PT Lowered to $130 at Stifel
August 7, 2024 2:03 PM EDTStifel analyst Rick Wise lowered the price target on Zimmer Biomet (NYSE: ZBH) to $130.00 (from $135.00) while maintaining a Buy rating.
The analyst comments "We left Zimmer's 2Q24 earnings call better-appreciating the many fundamental positives and sales growth drivers. We were reminded that over... More
